PG&E (PCG) Stock Short-Circuits in 2025 as Regulatory Risk Sparks Investor Jitters

PG&E Corp (NYSE:PCG) is one of the most oversold S&P 500 stocks so far in 2025. After a relatively better performance in 2024, PG&E stock has been a laggard in 2025 with declines... Read more »

Industry-Wide Tariffs Loom Over the Healthcare Sector. Here Are 2 Stocks That Can Weather the Storm.

President Trump’s tariffs could erode healthcare companies’ profits, but some may perform well regardless. Eli Lilly and Novartis have taken steps to mitigate the potential impact. Both drugmakers are innovative, deliver strong... Read more »

Novartis Raises Operating Income Outlook After Strong Q2 Performance, Initiates $10 Billion Stock Buyback (CORRECTED)

Editor’s Note: The title of the story has been corrected to reflect that the outlook was raised, instead of the erroneous “outlook cut” mentioned in the original title. Swiss pharmaceutical giant Novartis... Read more »

The Stock Market Did Something for Just the 6th Time Since 1957. History Says It Signals a Big Move for the S&P 500 Over the Coming Year.

The S&P 500 just delivered one of the greatest three-month rallies in its storied history, gaining 25% and reaching a new record high on Thursday. History shows the S&P 500 has always... Read more »

5 Brilliant High-Yield Midstream Stocks to Buy Now and Hold for the Long Term

The midstream sector is benefiting from increased natural gas demand. There are several strong stocks in the space with yields between 4% and 10%. Not only do these stocks have high yields,... Read more »